StockTipsArenaBeta

BUY Lupin Limited — Pradeep Haldar, PHD Capital

BUYLupin Limited
Lupin share price target & all analyst calls

byPradeep Haldar, PHD CapitalHorizon: 1 year31 Jul 2026via Business Today

Entry₹2,417.9Inferred
Target₹2,850
Total upside +17.87% (call closed)
Stop loss₹2,050-15.22% risk
Exit₹2,05015 Sept 2026, 12:09 pm
Stop-loss hit-15.22%
Follow Pradeep Haldar for new callsGet alertsWatch LUPIN for new buy/sell callsGet alertsSee 12 active Long-term calls on LUPINSee 214 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026
44 supporting3 neutral10 opposing
Supports the BUY call (44)

Lupin receives US FDA approval for Modafinil 100 mg, 200 mg tablets

NewsCnbc-Tv18·4 Sept · 1w ago

(opens in new tab)

Lupin Ltd has received approval from the U.S. FDA for its Modafinil Tablets, USP.

BSE · Company Update·4 Sept · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·28 Aug · 2w ago

Lupin wins ruling on Vertex patents for cystic fibrosis drug

NewsCnbc-Tv18·26 Aug · 3w ago

(opens in new tab)

7 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·27 Aug · 3w ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (10)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·27 Aug · 3w ago

Lupin share falls 2%; Citi downgrades to Sell, cuts target price to Rs 2,050

NewsEt-Markets·27 Aug · 3w ago

(opens in new tab)

Lupin share price: Citi downgrades, cuts target; Bernstein sees Kalydeco ruling as key positive

NewsCnbc-Tv18·27 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Lupin

All analyst calls on Lupin

More from Pradeep Haldar, PHD Capital

Every call and its outcome